Fogarty International Center

Fogarty International Center

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities NIH funding opportunities focusing on global health and foreign collaboration. HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required) (RFA-AI-19-045) AIDS Application Due Date: November 18, 2019 NIAID is soliciting applications from domestic and foreign institutions to serve as Clinical Trials Units (CTUs) for NIH HIV/AIDS Clinical Trials Networks. A priority is placed on reaching populations severely impacted by the HIV/AIDS epidemic whose participation will help address priorities for NIH HIV/AIDS research. These populations include, but are not limited to women, adolescents, sexual and gender as well as other minorities, people who inject drugs in the United States, and populations in low and middle-income countries. NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply. Biological Testing Facility Access For Contraceptive Development (X01 Clinical Trial Not Allowed) (PAR-19-263) Application Receipt/Submission Date(s): July 1, 2019 Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) (PAR-19-264) Application Receipt/Submission Date(s): July 10, 2019; December 10, 2019; and more NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity. SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed) (RFA-ES-19-009) Application Receipt Date(s): July 31,2019

Funding News

NIH funding news that may be relevant to global health researchers.

• Notice of Change to Eligibility Requirements to the International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) (NOT-TW-19-004)
• Notice of Intent to Publish a Funding Opportunity Announcement for:
  Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) (NOT-OD-19-100)
  Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) (NOT-OD-19-104)
• Notice of NICHD Participation in PAR-18-822 "Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)" (NOT-HD-19-010)

Upcoming Deadlines

• BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa from NHLBI
  Updated application deadline: June 11, 2019
• Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions from NHBLI and NINDS
  Application deadline: July 8, 2019
• Global Infectious Disease Research Training Program
  Application deadline: July 25, 2019
• U.S.-South Africa Program for Collaborative Biomedical Research Phase 2
  HIV/AIDS (R01 Clinical Trial Optional) (RFA-AI-19-022) and (U01 Clinical Trial Optional) (RFA-AI-19-023)
  Infectious Diseases (R01 Clinical Trial Optional) (RFA-AI-19-024) and (U01 Clinical Trial Optional) (RFA-AI-19-025)
  Application deadline: July 26, 2019
• Global Brain and Nervous System Disorders Research Across the Lifespan
  Application deadline: November 7, 2019
• Emerging Global Leader Award
  Application deadline: November 7, 2019
• Chronic, Noncommunicable Diseases and Disorders Research Training
  Application deadline: November 12, 2019
• Ecology and Evolution of Infectious Diseases (EEID)
  Application deadline: November 20, 2019